A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the bioequivalence of the combination test agent,
prednisolone acetate 1.0% and tobramycin 0.3% ophthalmic suspension compared to PredForte
(prednisolone acetate 1.0%) ophthalmic suspension. Bioequivalence will be measured by
comparing aqueous humor concentrations of prednisolone acetate.